1. Tumor Necrosis Factor-Like Weak Inducer of Apoptosis (TWEAK) Enhances Activation of STAT3/NLRC4 Inflammasome Signaling Axis through PKCδ in Astrocytes: Implications for Parkinson's Disease.
- Author
-
Samidurai M, Tarale P, Janarthanam C, Estrada CG, Gordon R, Zenitsky G, Jin H, Anantharam V, Kanthasamy AG, and Kanthasamy A
- Subjects
- Animals, Apoptosis, Astrocytes pathology, Cell Survival, Cells, Cultured, Cytokine TWEAK blood, Cytokine TWEAK genetics, Disease Models, Animal, Dopaminergic Neurons pathology, Humans, Inflammation Mediators metabolism, Mice, Mitochondria metabolism, Oxidative Stress drug effects, Parkinson Disease pathology, Protein Kinase C-delta genetics, Reactive Oxygen Species antagonists & inhibitors, Reactive Oxygen Species metabolism, Signal Transduction drug effects, TWEAK Receptor metabolism, Astrocytes metabolism, CARD Signaling Adaptor Proteins metabolism, Calcium-Binding Proteins metabolism, Cytokine TWEAK metabolism, Inflammasomes metabolism, Parkinson Disease metabolism, Protein Kinase C-delta metabolism, STAT3 Transcription Factor metabolism
- Abstract
Astrocytic dysfunction has been implicated in Parkinson's disease (PD) pathogenesis. While the Tumor necrosis factor-like weak inducer of apoptosis (TWEAK)/Fn14 signaling axis is known to play a role in PD-like neuropathology, the molecular mechanisms that govern this process remain poorly understood. Herein, we show that TWEAK levels are elevated in PD serum compared to controls. Moreover, using both U373 human astrocyte cells and primary mouse astrocytes, we demonstrate that TWEAK induces mitochondrial oxidative stress as well as protein kinase C delta (PKCδ) and signal transducer and activator of transcription 3 (STAT3) activation, accompanied by NLRC4 inflammasome activation and upregulation and release of proinflammatory cytokines, including IL-1β, TNF-α, and IL-18. Mechanistically, TWEAK-induced PKCδ activation enhances the STAT3/NLRC4 signaling pathway and other proinflammatory mediators through a mitochondrial oxidative stress-dependent mechanism. We further show that PKCδ knockdown and mito-apocynin, a mitochondrial antioxidant, suppress TWEAK-induced proinflammatory NLRC4/STAT3 signaling and cellular oxidative stress response. Notably, we validated our in vitro findings in an MPTP mouse model of PD and in mice receiving intrastriatal administration of TWEAK. These results indicate that TWEAK is a key regulator of astroglial reactivity and illustrate a novel mechanism by which mitochondrial oxidative stress may influence dopaminergic neuronal survival in PD.
- Published
- 2020
- Full Text
- View/download PDF